EUBIOTECH2026 | Biotechnology Conference | Bioengineering Conference | Top Conference in Biotechnology | Paris | France

Prof. Guido Kroemer

University of Paris, France

Title: Chemical biological manipulation of the endocrine system: the example of ACBP/DBI

Guido Kroemer is currently Professor at the Faculty of Medicine of the University of Paris, Director of the research team "Metabolism, Cancer and Immunity" of the French Medical Research Council (INSERM), Director of the Metabolomics and Cell Biology platforms of the Gustave Roussy Comprehensive Cancer Center, and Hospital Practitioner at the Hôpital Européen George Pompidou, Paris, France. He previously held appointments in Austria (University of Innsbruck), China (Suzhou Institute for System Medicine), Italy (University of Rome Tor Vergata, Rome), Spain (Severo Ochoa Institute, Madrid), Sweden (Karolinska Institute, Stockholm) and the US (Burnham Institute, Sand Diego). He is fluent in German, English, French, Italian and Spanish.

Dr. Kroemer’s work focuses on the pathophysiological implications of cell stress and death in the context of aging, cancer and inflammation. With over 1600 articles including 74 in the ‘CNS’ Journals Cell (17 papers), Nature (6), Nature Medicine (24), Science (19) and Science Translational Medicine (8), and an h-index of 303, he is Europe’s most cited researcher in biomedical research. He is also the worldwide most cited researcher in biochemistry, cell biology, as well as molecular biology.

His contributions have been recognized with multiple awards including the most prestigious cancer research and immunology prizes from Belgium (Baillet-Latour Health Prize), France (Prix Duquesne, Prix Léopold Griffuel, Grand Prix Ruban Rose), Spain (International Prize for Oncology Ramiro Carregal, Boulle-SEI Award) and Switzerland (Brupbacher Prize), the European Union-sponsored Descartes Prize, as well as the most important Italian science prize (Lombardia & Ricerca Prize). He also received two European Research Council (ERC) Advanced Investigator Awards.

He is member of the Austrian Academy of Sciences, Academia Europaea, European Academy of Sciences (EAS), Chinese Academy of Engineering (CAE), European Academy of Sciences and Arts (EASA), European Academy of Cancer Sciences (EACS), European Academy of Engineering (EAE), European Molecular Biology Organization (EMBO), German Academy of Sciences (Leopoldina), Institut Universitaire de France (IUF) and Spanish Royal Academy of Sciences. He is the Founding President of the European Academy of Tumor Immunology (EATI), as well as the President of the European Network for Cancer Immunotherapy (ENCI).

Prof. Ulo Langel

Stockholm University, Sweden

Title: Cell-penetrating peptides for new pharmacology

Ülo Langel is a Professor Emeritus at the Department of Biochemistry and Biophysics, Stockholm University, and at the Institute of Technology, Tartu University. Prof. Langel graduated from Tartu University, Tartu, Estonia, as bioorganic chemist in 1974; he has received his PhD degree twice: in 1980 from Tartu University, Tartu, Estonia (bioorganic chemistry), and in 1993 from Tartu University/Stockholm University (biochemistry/neurochemistry). His professional experience includes a career at Tartu University, Tartu, Estonia (from junior research fellow to Associate Professor, Visiting Professor, and Professor 1974-now); The Scripps Research Institute, La Jolla, CA, USA (Associate Professor, and Adjunct Professor 2000-now); and Stockholm University (from research fellow to Associate Professor, Professor and Chairman, 1987-now). He is a Honorary Professor at Ljubljana University, Slovenia. He was a Chairman of the Board of small companies Pepfex (Stockholm) and Cepep (Estonia) and member of the Board of Orexo (Sweden). In 2013 he was elected a member of Academia Europaea and in 2015, a foreign member of the Estonian Academy of Sciences.

Prof. Langel has been selected as a Fellow Member of International Neuropeptide Society (1995), and is a member of International Society for Neurochemistry, European Peptide Society, Swedish Biochemical Society and Estonian Biochemical Society. He has been awarded a White Star Order, 4th class, by Estonian Republic. He has been invited lecturer at numerous international conferences, and is a coauthor of more than 480 scientific articles and 20 approved or pending patents. His research interest is in neurochemistry where his research is aimed to study peptides, particularly neuropeptide receptors, and in drug delivery by cell-penetrating peptides.

Prof. Frieder W. Scheller

University of Potsdam, Germany

Title: Molecularly Imprinted Polymers: From Lab to Life

Prof. Frieder W. Scheller initiated the research and development of electrochemical biosensors in Germany. Since 1993, he has been Professor of Analytical Biochemistry at the University of Potsdam and in 2001 and 2002, President of the German Society of Biochemistry and Molecular Biology. From 2004 to 2007, he was the Vice-President of the University of Potsdam and since 2007, Head of the Department of Biomimetic Materials at the Fraunhofer Institute of Biomedical Engineering. He graduated more than 50 PhD students from Germany, China, Thailand, Russia, the USA, Turkey, and Italy. He published more than 550 scientific papers and edited 4 books. He was co-organizer of the World Congresses on Biosensors in Berlin in 1998, organized four ANALYTICA Conferences in Munich, was a board member of ten German Biosensor Symposia, and initiated the 1st European Biosensor Symposium in Potsdam in 2017.

He received the National Science and Technology Award of the German Democratic Republic in 1984, the Beckurts Award from the Federal Ministry of Germany in 1993 and has been a member of the Berlin-Brandenburg Academy of Sciences since 1993. He is an Honorary Member of the Dresdner Forschungsgesellschaft für Sensortechnik, received the Award of the Bioelectrochemistry Division of ISE in 2007, and the Anthony and Alice Turner Biosensor Award in 2023.

Prof. Chris Bowler

CNRS, INSERM, Université PSL, France

Title: Exploring the Tara Oceans multiverse

Chris Bowler is research director at the CNRS and director of the Phytogenomics Laboratory at the Institut de biologie de l'École normale supérieure in Paris. He received his PhD from the University of Ghent in Belgium, followed by postdoctoral studies at the Rockefeller University in New York. In 1994 he established his own laboratory working on signaling in plants and marine diatoms at the Stazione Zoologica in Naples, Italy, and in 2003 he took up his current position in Paris. He has been a member of EMBO since 1995, received the CNRS Silver Medal in 2010, ERC Advanced Awards in 2012 and 2018 and the Grand Prix Scientifique de la Fondation Louis D de l'Institut de France in 2015. In 2016-2017 he was a Fellow at the Radcliffe Institute of Advanced Studies at Harvard University, USA. In 2018 he was elected member of the French Academy of Agriculture, and during the academic year 2020-2021 he held the annual chair as Professor in biodiversity and ecosystems at the Collège de France. Currently, his main research interest is the understanding of the response marine diatoms to environmental signals, through functional and comparative genomics. Since 2021 he is the scientific director of the Tara Oceans project to explore the biodiversity, ecology and evolution of plankton in the world's ocean. In 2023 he was elected member of the Accademia dei Lincei in Italy.

Prof. Tomasz Twardowski

Polish Academy of Sciences in Poznań, Poland

Title: How to feed 10 billion people by 2050?

Will update soon.

Prof. Ibrahim M. Banat

University of Ulster, UK

Title: To be confirmed.

A professor of Microbial Biotechnology at the University of Ulster, UK. He has over 35 years’ experience in academic and research institutions in Europe and internationally and has been involved in several collaborative projects funded by the EU-FP-7, H20-20 and Horizon Europe and other international academic, commercial and industrial establishments. Research interests include biosurfactant and bio-actives production and potential utilization in environmental oil pollution control and bioremediation. Recently he is concentrating on investigating biomedical, pharmaceutical, health and cosmetics related applications of microbial surface-active agents. Prof. Banat also has interest and extensive experience in fermentation technologies, biofuel, wastewater treatment, thermophilic bacteria, bioethanol and related microbial biotechnology applications. Professor Banat has >350 publications in different areas of Microbial Biotechnology with >49.000 citations and (h-index = 104) citation as of June 2025 and according to Google Scholar see; http://scholar.google.co.uk/citations?user=YwfP5SYAAAAJ&hl=en&oi=ao Professor Banat also enjoys an advanced ranking within the world scientific community in his field of expertise, see; https://www.adscientificindex.com/scientist.php?id=1037362

Prof. Chenzhong Li

The Chinese University of Hong Kong, China

Title: Energy Medicine for Disease Theranostics

Prof. Chenzhong Li is the X.Q. Deng Presidential Chair Professor at the Chinese University of Hong Kong, Shenzhen (CUHKSZ), the editors-in-chief of the journal Biosensor and Bioelectronics and the journal Technology and Innovation of the National Academy of Inventors, the society journal of the National Academy of Inventors.

Before he joined in CUHKSZ, he was the Research Officer at the Biotechnology Research Institute (Montreal) of Canada National Research Council, the World’s Ahead Professor of Biomedical Engineering at Florida International University, the NSF program director of Biosensing Program, and the Professor of Biomedical Engineering and Biochemistry at Tulane University. His scientific research direction is mainly the research and development of bio-optoelectronics and bio-sensing chips, with a preference for the development of applied technologies, especially in the diagnosis of, IVD, smart medical care, energy medicine, environmental protection and food testing. In terms of disease treatment, it mainly focuses on the diagnosis and treatment of mental diseases and degenerative diseases through biophysical therapy including light, electricity, magnetism, music, etc.

He has received many awards and honors, including the Kauffman Entrepreneurship Professor Award in 2009 and 2011, the 2014 Japan Society for the Promotion of Science Visiting Professor Award, the 2016 American Brain Mapping Association Technology Development Pioneer Award, and the 2016 Minority Serving Institution Teacher Award. Cancer Research Award (awarded by the American Association for Cancer Research (AACR)), and the 2019 IEEE Distinguished Lecturer Award.

By 2024, he has published nearly 200 SCI academic papers including Nature BME, Nature Nano, Advance Science, JACS, Biosensors Bioelectronics, ACS Nano etc., and is the main inventor of 20 patents. He was the founder and technical director of three start-up companies in China, the United States, and Canada.

Prof. Thomas Vogl

University Hospital Frankfurt, Germany

Title: Interventional Oncology

Prof. Dr. Thomas Vogl, MD, is a Professor of Radiology at the University Hospital in Frankfurt with expertise in interventional oncology such as transarterial chemoembolization, transpulmonary chemoembolization, thermal ablation, vascular procedures, MDCT, MRI, evaluation of contrast agent, MR-guided procedures, subjects upon which he regularly publishes and lectures nationally and internationally. His special focus is on head and neck tumors as well as primary and secondary liver and lung tumors.

Plenary Speakers